| Literature DB >> 10591342 |
Abstract
Japan approved the use of low-dose oral contraceptives (OCs) in June 1999, after more than 35 years of debate. The debate leaves a legacy of misinformation about and various sources of resistance to OCs. Benefits are expected to include greater control for women over their fertility and a reduction in the high rates of unplanned pregnancies and abortions. Successful implementation of the new policy will require a new emphasis on women's health, including the provision of accurate information about OCs and their associated adverse effects, a women-centered approach to gynecological practice, and the promotion of condoms as protection from sexually transmitted diseases, rather than as contraception alone.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10591342 DOI: 10.1001/jama.282.22.2173
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272